Skip to content

Clinical trials

Completed Schizophrenia trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: South Korea Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20045
20053
20061
20077
200812
20094
20108
20118
201211
20134
20142
20164
20174
20182
20202
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed81

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Hospital9
Janssen Korea, Ltd., Korea8
Janssen Research & Development, LLC7
Otsuka Pharmaceutical Development & Commercialization, Inc.6
Alkermes, Inc.5
AstraZeneca5
Korea Otsuka Pharmaceutical Co., Ltd.5
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.4
Sumitomo Pharma Co., Ltd.4
Boehringer Ingelheim3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia81
Psychotic Disorders11
Bipolar Disorder2
Hallucinations2
Mental Disorders2
Recurrence2
Alcoholism1
Autistic Disorder1
Disease1
Metabolic Syndrome1

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.